Some thoughts on the new variant, B.1.1.529 (aka ‘Nu’):
First and foremost, there is reason for concern, but nearly everything is still unclear at this moment.
The incredible team of scientists in South Africa that identified the variant along with @WHO and others are doing the research right now to answer 👇 important questions…
The imposition of punishing restrictions will disincentivize other countries from transparently sharing similar news in the future.
This isn’t just a problem in this pandemic, but transparency has been an issue in other outbreaks.
What does that mean in practice?
Imagine a country like Turkey identifies a worrisome variant that seems to undermine the protection of our vaccines.
But sounding the alarm brings travel bans, economic losses and a negative depiction in international press.
What would you do?
It’s also worth noting that this is exactly what everyone calling for global vaccine equity has been screaming about.
Even as wealthy countries roll out expansive booster campaigns, many countries are still waiting for enough doses to give first shots.
An unvaccinated population—anywhere in the world—gives the virus more chances to mutate and evolve.
And policies in wealthy countries—including purchasing and stockpiling more doses than needed—have made it harder to get people vaccinated, especially those in sub-Saharan Africa.
At one point, vaccines produced IN AFRICA were being sent to Europe because of contractual requirements.
I understand many people are worried. We’ll know more in the coming days & weeks.
But in the meantime, take a moment to think of the many healthcare workers around the world still on the frontlines despite not yet having access to a vaccine.
Seven years ago today I walked out of the hospital after surviving Ebola.
That day at a news conference—my knees shaking—I begged the world to focus on the still-raging outbreak in West Africa. Instead, when the immediate threat was over, we moved on.
Years later, Covid hit 🧵
There were so many lessons we should've learned from Ebola.
Foremost amongst them was the importance of global solidarity in responding to global health threats.
But that's a lesson we just didn't learn. Instead, we dodged a bullet and we moved on. thelancet.com/journals/lance…
Few people knew that the New York City hospital where I was treated for Ebola had more doctors than Guinea, Liberia, and Sierra Leone—the 3 hardest-hit countries of the Ebola outbreak—COMBINED.
And SO many frontline providers in those countries died of Ebola during the outbreak.
Who likely needs a booster: organ transplant recipients, the immunosuppressed (e.g. on chemotherapy), and some J&J recipients [particularly the elderly].
Everyone else? There’s no data they are indicated yet.
If we want to end the pandemic and make a long-term difference, we need more than just donated doses.
US financial & technical support can help build critical vaccine manufacturing capacity in countries where production is severely limited or nonexistent. doctorswithoutborders.org/what-we-do/new…
As Covid cases decline, our job in the ER feels just like it used to for the first time since the virus surged into our hospitals.
It was a year ago that we made this animated video to show what a “normal” day on the Covid front lines looked like...
Even if our job is getting back to normal, to be honest, it was never a cakewalk. We see really sick patients every shift, and sadly some of our patients die.
But Covid brought a whole new level of chaos and craziness.
We prioritized high-risk groups for vaccination. You know, like the elderly. As in, some of the same people whose risk of dying was actually just kinda high at baseline.
Did some of them die after getting a vaccine? Yes.